| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Laboratorio de Investigación Cardiovascular (T.S., A.D.-R., E.C.-S., A.O.), Hospital Universitario Virgen del Roció, Universidad de Sevilla, and Centro Andaluz de Biología Molecular & Medicina Regenerativa (A.H., A.H.-L.), Sevilla, Spain.
Correspondence to Tarik Smani, PhD, Laboratorio de Investigación Cardiovascular, Quirófanos Experimentales, Hospital General Universitario Virgen del Rocío, Avenida Manuel Siurot s/n, E-41013 Sevilla, Spain. E-mail tasmani{at}us.es
Urocortin has been shown to produce vasodilatation in several arteries, but the precise mechanism of its action is still poorly understood. Here we demonstrate the role of store operated Ca2+ entry (SOCE) regulated by Ca2+-independent phospholipase A2 (iPLA2) in phenylephrine hydrochloride (PE)-induced vasoconstriction, and we present the first evidence that urocortin induces relaxation by the modulation of SOCE and iPLA2 in rat coronary artery. Urocortin produces an endothelium independent relaxation, and its effect is concentration-dependent (IC50
4.5 nmol/L). We show in coronary smooth muscle cells (SMCs) that urocortin inhibits iPLA2 activation, a crucial step for SOC channel activation, and prevents Ca2+ influx evoked by the emptying of the stores via a cAMP and protein kinase A (PKA)–dependent mechanism. Lysophophatidylcholine and lysophosphatidylinositol, products of iPLA2, exactly mimic the effect of the depletion of the stores in presence of urocortin. Furthermore, we report that long treatment with urocortin downregulates iPLA2 mRNA and proteins expression in rat coronary smooth muscle cells. In summary, we propose a new mechanism of vasodilatation by urocortin which involves the regulation of iPLA2 and SOCE via the stimulation of a cAMP/PKA-dependent signal transduction cascade in rat coronary artery.
Key Words: urocortin iPLA2 vasoconstriction store operated Ca2+ entry cAMP-PKA
This article has been cited by other articles:
![]() |
S. Wang, Y. Zhang, W. G. Wier, X. Yu, M. Zhao, H. Hu, L. Sun, X. He, Y. Wang, B. Wang, et al. Role of store-operated Ca2+ entry in adenosine-induced vasodilatation of rat small mesenteric artery Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H347 - H354. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Calderon-Sanchez, C. Delgado, G. Ruiz-Hurtado, A. Dominguez-Rodriguez, V. Cachofeiro, M. Rodriguez-Moyano, A. M. Gomez, A. Ordonez, and T. Smani Urocortin induces positive inotropic effect in rat heart Cardiovasc Res, June 13, 2009; (2009) cvp161v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Calderon-Sanchez, M. Fernandez-Tenorio, A. Ordonez, J. Lopez-Barneo, and J. Urena Hypoxia inhibits vasoconstriction induced by metabotropic Ca2+ channel-induced Ca2+ release in mammalian coronary arteries Cardiovasc Res, April 1, 2009; 82(1): 115 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Smani, T. Patel, and V. M. Bolotina Complex regulation of store-operated Ca2+ entry pathway by PKC-{varepsilon} in vascular SMCs Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1499 - C1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Saleh, A. P. Albert, C. M. Peppiatt-Wildman, and W. A. Large Diverse properties of store-operated TRPC channels activated by protein kinase C in vascular myocytes J. Physiol., May 15, 2008; 586(10): 2463 - 2476. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |